This streamlined NGS tumor profile maximizes yield by analyzing DNA and RNA in a single test to detect SNV/indels, CNVs, and/or RNA Fusions in 50 genes, plus MSI and TMB. PD-L1 is available. Results inform of therapy options, prognostic implications, and clinical trial opportunities.